null

Litifilimab (Anti-CLEC4C) Biosimilar Antibody

SKU:
HDBS0135
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CLEC4C
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Litifilimab (Anti-CLEC4C) Biosimilar Antibody (HDBS0135)

The Litifilimab Biosimilar Anti-CLEC4C Antibody offered by Assay Genie (AB10010) is a cutting-edge tool for researchers studying CLEC4C, a cell surface receptor with diverse functions in the immune system. This antibody, developed through advanced biotechnology, is highly specific and sensitive for targeting CLEC4C in human samples.CLEC4C, also known as Dectin-2, is a key player in the recognition and response to pathogens, particularly fungi. It is involved in immune signaling pathways that trigger inflammation and host defense mechanisms. The ability of this antibody to detect and bind to CLEC4C enables precise analysis and visualization of its expression and localization in various cell types.Research on CLEC4C holds promise for uncovering new insights into immune responses to infections, inflammatory diseases, and cancer.

By studying the function and regulation of CLEC4C, scientists can potentially identify novel therapeutic targets and develop innovative treatments for a range of health conditions.For researchers seeking to delve deeper into the molecular mechanisms of CLEC4C and its role in immunity, the Litifilimab Biosimilar Anti-CLEC4C Antibody is a valuable tool that offers reliability, accuracy, and reproducibility in experimental settings. Harness the power of this antibody to advance your research and contribute to the growing body of knowledge in immunology and disease biology.